Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR)
This completed pilot study assessed the feasibility of remotely evaluating resting heart rate and heart rate variability in survivors of Hod…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer [Phase 1, Phase 2]
This document details an ongoing Phase 1/2 clinical trial evaluating cobolimab in combination with dostarlimab in pediatric and young adult …
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine [Phase 1]
A Phase 1 clinical trial evaluating a haploidentical bone marrow transplant using post-transplant cyclophosphamide and bendamustine has comp…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant [Phase 1]
Phase 1 study evaluating olaparib in combination with high-dose chemotherapy for relapsed or refractory lymphomas undergoing stem cell trans…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Personalized NK Cell Therapy in CBT [Phase 2]
A Phase 2 trial from MD Anderson is evaluating personalized NK cell therapy across several hematologic cancers. The study is currently recru…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Auto Stem Cell Transplant for Lymphoma Patients [Phase 2]
This Phase 2 clinical trial registry entry describes autologous stem cell transplantation as a treatment approach for non-Hodgkin lymphoma a…
-
CLINICAL_TRIALS other · 2025-11-03Clinical Trial Update: BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma [Phase 2]
Phase 2 trial of BrECADD therapy for stage 2 B-IV Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) [Phase 1]
Phase 1 trial evaluating autologous/allogeneic TGF-beta-resistant LMP-specific cytotoxic T lymphocytes for lymphoma; the study is active but…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning before allogeneic donor stem cell transplantation in patients with high-risk hematol…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Two Step Haplo With Radiation Conditioning [Phase 2]
Phase 2 clinical trial update describing two-step haploidentical transplantation with radiation conditioning for hematologic diseases, curre…
-
FDA approval · 2025-10-27FDA Approved: LOMUSTINE — Original Application (Carnegie Pharmaceuticals LLC)
FDA approves Carnegie Pharmaceuticals LLC's original application for lomustine (LOMUSTINE), making a generic version of the chemotherapy dru…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
This clinical trial update reports Phase 2 results for Brentuximab vedotin (SGN-35) in transplant-eligible patients with relapsed or refract…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ATLCAR.CD30.CCR4 for CD30+ Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of the monoclonal antibody IMT-009 in various advanced solid tumors and lymphomas, with t…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors [Phase 1]
Phase 1 pediatric trial evaluating alpha/beta CD19+ depleted haploidentical transplantation in combination with Zoledronic acid (Zometa) for…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers [Phase 2]
Phase II trial of XmAb20717 for advanced rare cancers has been suspended, with eligibility including microsatellite instability-high cancers…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial [NA]
Clinical trial update confirming completion of the TECHS trial, which tested a telehealth exercise program to improve cardiovascular health …
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating PET-adapted first-line therapy with nivolumab for advanced Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial update describes evaluating a five-drug combination (doxorubicin, vinblastine, dacarbazine, brentuximab vedotin, an…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Expanded Access program for AVM0703 is available to eligible patients with several solid tumor and blood cancer indications, including gliob…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the combination of nivolumab and lenalidomide in relapsed or refractory lymphomas (non-Hodgkin an…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies [EARLY_Phase 1]
An early-phase trial evaluating Darzalex Faspro (daratumumab and hyaluronidase-fihj) given before desensitization and allogeneic stem cell t…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
The CREST study update shows the cardiovascular reserve evaluation trial in transplant survivors is currently active but not recruiting, spo…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Integrated Actionable Aging Assessment for Cancer Patients Pilot [NA]
This entry summarizes a pilot trial from University of Colorado, Denver to develop an integrated aging assessment for cancer patients; the s…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation [NA]
This document provides an update on a clinical trial evaluating cardiac screening in survivors of Hodgkin lymphoma treated with mediastinal …